- Volatility is at a recent 2 week high. A high volatility of stock movement indicates uncertainty.
- MACD is crossing MACD signal line at 0.1. MACD crossing signal line is bullish signal.
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes fromFinra
Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
(Bloomberg) -- Carlos Slim and his family have accumulated stakes worth $230 million in oil refiner PBF Energy Inc. and pipeline operator PBF Logistics LP, continuing to snap up stock even as the shares have slumped.The family investment vehicle, Control Empresarial de Capitales, is now PBF Energy’s largest shareholder and the second-biggest in PBF Logistics.They emerged as investors in the companies in 2017 and added about $70 million in 2020, with the bulk of the purchases following the outbre...
Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today
Investors need to pay close attention to PBF Energy (PBF) stock based on the movements in the options market lately.
PBF Energy Inc. (NYSE:PBF) announced today that it will release its earnings results for the fourth quarter 2020 on Thursday, February 11, 2021. The company will host a conference call and webcast regarding quarterly results and other business matters on Thursday, February 11, 2021, at 8:30 a.m. ET.
PBF Energy Inc. (NYSE:PBF) today announced that members of its management team will participate in the Sankey Research Virtual Refining Conference on January 4, 2021, the 3rd Annual Mizuho Virtual Refining Conference on January 5, 2021, and the Goldman Sachs Global Energy Conference 2021 on January 6, 2021.
Unlike many oil and gas companies, NGL Energy Partners (NYSE: NGL) was actually able to keep rising through the first half of the year even after the master limited partnership slashed its distribution to investors. Irish biotech Amarin (NASDAQ: AMRN) was pummeled back in March after a trial judge in Nevada invalidated several of the patents surrounding Vascepa, a modified fish oil treatment that lowers triglycerides. The judge called the company's intellectual property "obvious" and nullified...